Vanessa Pereira Selected Research

potassium channel protein TREK-1

1/2018	Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin.
3/2014	Synthesis and structure-activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel.
1/2013	Activation of TREK-1 by morphine results in analgesia without adverse side effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vanessa Pereira Research Topics

Disease

11	Pain (Aches) 01/2023 - 01/2013
3	Neuralgia (Stump Neuralgia) 01/2023 - 01/2018
3	Neoplasms (Cancer) 12/2021 - 01/2018
3	Peripheral Nervous System Diseases (PNS Diseases) 12/2021 - 10/2013
2	Hypersensitivity (Allergy) 12/2021 - 07/2021
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2018
2	Osteoarthritis 01/2018 - 01/2018
2	Cold Hypersensitivity 01/2018 - 05/2011
1	Channelopathies 12/2021
1	Polyps 01/2018
1	Bone Neoplasms (Bone Cancer) 01/2018
1	Myalgia 01/2018
1	Congenital Pain Insensitivity 12/2015
1	Hyperalgesia 12/2014
1	Respiratory Insufficiency (Respiratory Failure) 01/2013
1	Constipation 01/2013
1	Chronic Pain 01/2013

Drug/Important Bio-Agent (IBA)

6	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 05/2011
3	Ion Channels (Ion Channel)IBA 12/2021 - 05/2011
3	potassium channel protein TREK-1IBA 01/2018 - 01/2013
3	Opioid Analgesics (Opioids)IBA 10/2017 - 01/2013
2	Analgesics (Analgesic Drugs)IBA 01/2023 - 01/2018
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2023 - 01/2018
2	Potassium Channels (Potassium Channel)IBA 12/2021 - 07/2021
2	Voltage-Gated Sodium ChannelsIBA 10/2017 - 12/2015
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	entinostat (MS 275)IBA 12/2021
1	Histone Deacetylase InhibitorsIBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2021
1	Messenger RNA (mRNA)IBA 07/2021
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	Freund's AdjuvantIBA 01/2018
1	Opioid Receptors (Opioid Receptor)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Annexin A6IBA 01/2018
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Riluzole FDA LinkGeneric 01/2018
1	Conotoxins (Conotoxin)IBA 01/2018
1	Tetrodotoxin (Tetradotoxin)IBA 10/2017
1	Serotonin (5 Hydroxytryptamine)IBA 10/2017
1	SodiumIBA 10/2017
1	Sodium Channels (Sodium Channel)IBA 12/2015
1	Dinoprostone (PGE2)FDA Link 12/2014
1	Morphine (MS Contin)FDA LinkGeneric 01/2013

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2018 - 05/2011
2	Analgesia 01/2018 - 01/2013
1	Ligation 01/2018
1	Pain Management 01/2018
1	Therapeutics 01/2013